| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435937A2 Composition comprising paracetamol and a bitterness masking component |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435927A2 Method for treating skin disorders |
| 07/14/2004 | EP1435921A1 Use of a multi-layer controlled-release tablet comprising ropinirole for the manufacture of medicament for the treatment of fibromyalgia |
| 07/14/2004 | EP1435918A1 Highly compressible ethylcellulose for tableting |
| 07/14/2004 | EP1435917A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 07/14/2004 | EP1435910A1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1315793A4 Methods for culturing human lung mast cells and uses thereof |
| 07/14/2004 | EP1248630B1 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512993A Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 07/14/2004 | CN1512987A Novel 1H-indazole compound |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512883A Crf受体拮抗剂 Crf receptor antagonist |
| 07/14/2004 | CN1512882A Reconstitutable parenteral composition containing COX-2 inhibitor |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1511835A Benzo-isoselenazole derivatives having anti inflammation, anti-tumor and anti-thrumbosis function and its use |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511828A Sufonic aniline derivatives and their medicinal use |
| 07/14/2004 | CN1511589A Biological compactable medicine carrier and its preparing method |
| 07/14/2004 | CN1511579A Chinese medicine preparation |
| 07/14/2004 | CN1511577A Medicine for treating primary and secondary headache |
| 07/14/2004 | CN1511553A Infantile antipyretic |
| 07/14/2004 | CN1511543A Fast curnig powder for inflammation and swelling |
| 07/14/2004 | CN1511541A Use of sodium selenite in producing medicine |
| 07/14/2004 | CN1511533A Use of bufadienolide in inhibiting vascularization |
| 07/14/2004 | CN1511531A Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 07/14/2004 | CN1511521A Use of goldenlarch bark acetic acid inhibiting vascularization |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1511514A Acetaminophen granule with slow releasing action and its preparing method |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157371C Monohydrate of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexancecarboxylate |
| 07/14/2004 | CN1157366C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 07/14/2004 | CN1157218C Medicine for curing rheumatism and rheumatoid arthritis |
| 07/14/2004 | CN1157213C Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma |
| 07/14/2004 | CN1157208C Medicated liquor for curing rheumatism and its production process |
| 07/14/2004 | CN1157205C Ointment for treating ostalgia |
| 07/14/2004 | CN1157185C Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 07/13/2004 | US6762320 Monoamine oxidase b inhibitors; alzheimer's disease, senile dementia |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762199 Ability to modulate the interaction of the ligand vcam-1 with its integrin receptor alpha 4 beta 1; treatment of inflammation, atherosclerosis, autoimmune disease |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762170 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | CA2313106C Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2259270C Pharmaceutical preparation containing nimesulide for oral administration |
| 07/13/2004 | CA2255652C Isobutylgaba and its derivatives for the treatment of pain |
| 07/13/2004 | CA2118859C Enantiomers of 1-[(4-chlorophenyl)-phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056868A2 Nf-hev compositions and methods of use |
| 07/08/2004 | WO2004056823A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |
| 07/08/2004 | WO2004056820A1 Benzoxazines and derivatives thereof as inhibitors of pi3ks |
| 07/08/2004 | WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056797A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056789A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivates |
| 07/08/2004 | WO2004056788A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/08/2004 | WO2004056747A1 Dhodh-inhibitors and method for their identification |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056366A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056357A1 Composition comprising diclofenac for treating otic pain and inflammation |
| 07/08/2004 | WO2004039377A8 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004024128A3 Modified release ketoprofen dosage form |
| 07/08/2004 | WO2004019927A3 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004014835A9 Resolvins: biotemplates for therapeutic interventions |
| 07/08/2004 | WO2004009072B1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003002058A9 Bone anabolic compounds and methods of use |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040132988 Immunoeffector compounds |
| 07/08/2004 | US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases |
| 07/08/2004 | US20040132824 Novel methods and compositions for alleviating pain |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |